Biodegradable and Eco-friendly Smart Hydrogels for the Sustained Intraperitoneal Release of Chemotherapeutics as a Novel Local Therapy Approach for Advanced Ovarian Cancer

Diana Rafael; FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON

Más información

Fecha de publicación: 2023
Objetivos: goal of HydroTheC is to provide a new injectable non-toxic Smart HG as a new delivery depo-system to significantly increase the standard-of-care therapeutic window and reduce the appearance of therapy resistance, thus increasing patient survival and welfare
Año de Inicio/Término: 2023-2026
Financiamiento/Sponsor: HORIZON-TMA-MSCA-PF-GF
Rol del Usuario: INVESTIGADOR(A) PATROCINANTE
Notas: Ovarian Cancer (OC) is usually diagnosed in advanced stages when metastasis into the intra-abdominal (i.a.) cavity already occurred. The OC standard-of-care efficacy is hampered by drugs high systemic toxicity and the early appearance of resistance. Thus, advanced OC remains an unmet clinical need,